Medicine and Dentistry
Liver Transplantation
100%
Colorectal Liver Metastasis
62%
Cholestasis
58%
Hepatectomy
53%
Surgery
43%
Liver Surgery
28%
Case Mix
27%
Cholangiocarcinoma
25%
Metastatic Carcinoma
25%
Bile Salt
25%
Liver Metastasis
24%
Cancer Surgery
23%
Biliary Tract Drainage
22%
Neoplasm
21%
Preoperative Chemotherapy
16%
Overall Survival
16%
Ischemia
15%
Randomized Controlled Trial
15%
Stricture
15%
Bile Duct Injury
14%
Colorectal Cancer
14%
Machine Perfusion
14%
Protein Intake
14%
Bile Duct Cancer
14%
Hepatic Portal Vein
14%
Liver Failure
13%
Magnetic Resonance Imaging
13%
Logistic Regression Analysis
13%
Primary Sclerosing Cholangitis
12%
Bile
12%
Injury
12%
Abdominal Cancer
12%
Perioperative Period
12%
Transplantation
12%
Roux-en-Y
10%
Disease
10%
Hepatocellular Carcinoma
10%
Acetylsalicylic Acid
10%
Surgeon
10%
Stenting
9%
Liver Graft
9%
Bleeding
9%
Cohort Study
8%
Emergency Medical Technician
8%
Prospective Cohort Study
8%
Cohort Analysis
8%
Portal Vein Thrombosis
8%
Choledochojejunostomy
7%
Health Literacy
7%
Cross Sectional Study
7%
Keyphrases
Colorectal Liver Metastases
40%
Liver Transplantation
37%
Liver Surgery
22%
Non-anastomotic Strictures
22%
Netherlands
18%
Liver
18%
Hospital Variation
16%
Perihilar Cholangiocarcinoma
16%
CIRSE
14%
Textbook Outcome
14%
National Cohort Study
14%
Synchronous Colorectal Cancer
14%
Liver Resection
13%
Hepatobiliary
12%
Postoperative Outcomes
11%
Transplantation
11%
Dutch
11%
Primary Sclerosing Cholangitis
11%
Resection
11%
Failure to Rescue
10%
30-day Mortality
10%
Roux-en-Y Hepaticojejunostomy
9%
Risk Factors
9%
Short-term Outcomes
9%
Abdominal Cancer Surgery
8%
Preoperative Chemotherapy
8%
Population-based Study
8%
Posthepatectomy Liver Failure
8%
Overall Survival
8%
Percutaneous Transhepatic Biliary Drainage
8%
Oncological Networks
8%
Practice Variation
7%
CCR5Δ32
7%
Anesthesia
7%
Perfusion Solution
7%
Biliary Drainage
7%
Hypothermic Machine Perfusion
7%
Survival Surgery
7%
University Medical Centre
7%
Circulatory Death
7%
Ischemic-type Biliary Lesion
7%
Randomized Trial
7%
Unplanned Readmission
7%
Late Presentation
7%
Feature Factors
7%
Hemoglobin-based Oxygen Carriers
7%
Radiological Risk
7%
Management Risk
7%
Management Outcome
7%
Physical Activity
7%